Zantac (ranitidine)
MDL 2924 (federal claims dismissed); state cases continue, S.D. Fla., Judge Robin L. Rosenberg
Filings
Coordinated
Bellwethers
Settlement
Wind-down
Most claims are resolved, dismissed or closed to new filings.
- Stage
- Resolved or winding down
- Campaign window
- Closing
- Coordination
- MDL 2924 (federal claims dismissed); state cases continue
- Court
- S.D. Fla.
- Judge
- Robin L. Rosenberg
- Category
- Drugs
- Defendants
- Sanofi, GSK, Pfizer, Boehringer Ingelheim
- Injuries
- Bladder Cancer, Stomach Cancer, Esophageal Cancer
Updated . Maintained by Jacob Malherbe.
New federal cases per week
Not tracked for this tort, because its cases are not centralized in one federal court.
Jacob Score: 28
Litigation strength from 0 to 100. Last reviewed Jul 20, 2026. How it's set
- Science
- Momentum
- Campaign
- Timeline
- Verdicts
What changed
- Sep 30, 2026
NewsSettlement in principle reached in California Ranitidine litigation
Watch this tort
Get Zantac developments at the top of the Monday briefing.
Who typically qualifies
1+ year use · Bladder, stomach, or esophageal cancer · Pre-2020 use
From campaign criteria. Qualification depends on each firm's review.
Related torts
- Ozempic and GLP-1 stomach injuries Coordinated (MDL or JCCP), 26 new cases in 7 days
- Depo-Provera and meningioma Coordinated (MDL or JCCP), 3 new cases in 7 days
- Suboxone and tooth decay Coordinated (MDL or JCCP), 2 new cases in 7 days
- Dupixent and lymphoma (CTCL) Coordinated (MDL or JCCP), 2 new cases in 7 days
Advertising on Zantac?
Mass Tort Ad Agency runs Meta tort campaigns for plaintiff firms and can show you what this tort's audience looks like.
Talk to Mass Tort Ad Agency